Noninvasive, medical management for non–ST-elevation acute coronary syndromes

Anderson, 2007, ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction, J Am Coll Cardiol, 50, e1, 10.1016/j.jacc.2007.02.013 Bassand, 2007, Guidelines for the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes, Eur Heart J, 28, 1598, 10.1093/eurheartj/ehm161 Fox, 2007, Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE), Heart, 93, 177, 10.1136/hrt.2005.084830 Carruthers, 2005, Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE), Heart, 91, 290, 10.1136/hrt.2003.031237 Kandzari, 2005, Influence of clinical trial enrollment on the quality of care and outcomes for patients with non–ST-segment elevation acute coronary syndromes, Am Heart J, 149, 474, 10.1016/j.ahj.2004.11.014 Fox, 2002, Interventional versus conservative treatment for patients with unstable angina or non–ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial, Randomized Intervention Trial of unstable Angina, Lancet, 360, 743, 10.1016/S0140-6736(02)09894-X Cannon, 2001, Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban, N Engl J Med, 344, 1879, 10.1056/NEJM200106213442501 Fox, 2007, Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006, JAMA, 297, 1892, 10.1001/jama.297.17.1892 Roe, 2005, Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non–ST-segment elevation myocardial infarction, Arch Intern Med, 165, 1630, 10.1001/archinte.165.14.1630 Tricoci, 2006, Clopidogrel to treat patients with non–ST-segment elevation acute coronary syndromes after hospital discharge, Arch Intern Med, 166, 806, 10.1001/archinte.166.7.806 Mandelzweig, 2006, The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004, Eur Heart J, 27, 2285, 10.1093/eurheartj/ehl196 Yusuf, 2006, Comparison of fondaparinux and enoxaparin in acute coronary syndromes, N Engl J Med, 354, 1464, 10.1056/NEJMoa055443 Blazing, 2004, Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non–ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial, JAMA, 292, 55, 10.1001/jama.292.1.55 Yusuf, 2003, Early and late effects of clopidogrel in patients with acute coronary syndromes, Circulation, 107, 966, 10.1161/01.CIR.0000051362.96946.15 1998, The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy, N Engl J Med, 339, 436, 10.1056/NEJM199808133390704 Goodman, 2000, Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q Wave Coronary Events, J Am Coll Cardiol, 36, 693, 10.1016/S0735-1097(00)00808-1 1996, The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes., N Engl J Med, 335, 775, 10.1056/NEJM199609123351103 Roe, 2006, The influence of risk status on guideline adherence for patients with non–ST-segment elevation acute coronary syndromes, Am Heart J, 151, 1205, 10.1016/j.ahj.2005.08.006 Mehta, 2006, Contraindications to cardiac catheterization in non–ST-elevation acute coronary syndromes: insights from the CRUSADE national quality improvement initiative, Eur Heart J, 27, S1 Stukel, 2005, Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare Patients with acute myocardial infarction, JAMA, 293, 1329, 10.1001/jama.293.11.1329 Blomkalns, 2005, J Am Coll Cardiol, 45, 832, 10.1016/j.jacc.2004.11.055 Sonel, 2005, Circulation, 111, 1225, 10.1161/01.CIR.0000157732.03358.64 Roe, 2006, Impact of congestive heart failure in patients with non–ST-segment elevation acute coronary syndromes, Am J Cardiol, 97, 1707, 10.1016/j.amjcard.2005.12.068 Han, 2006, Chronic kidney disease in patients with non–ST-segment elevation acute coronary syndromes, Am J Med, 119, 248, 10.1016/j.amjmed.2005.08.057 Haim, 2004, Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: does current treatment comply with guidelines?, Am Heart J, 147, 859, 10.1016/j.ahj.2003.11.014 Avezum, 2005, Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE), Am Heart J, 149, 67, 10.1016/j.ahj.2004.06.003 Rao, 2003, Poverty, process of care, and outcome in acute coronary syndromes, J Am Coll Cardiol, 41, 1948, 10.1016/S0735-1097(03)00402-9 Pilote, 2003, Universal health insurance coverage does not eliminate inequities in access to cardiac procedures after acute myocardial infarction, Am Heart J, 146, 1030, 10.1016/S0002-8703(03)00448-4 Bugiardini, 2006, Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography, Arch Intern Med, 166, 1391, 10.1001/archinte.166.13.1391 The TIMI IIIB Investigators, 1994, Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non–Q-wave myocardial infarction results of the TIMI IIIB trial, Circulation, 89, 1545, 10.1161/01.CIR.89.4.1545 McCullough, 1998, A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial, J Am Coll Cardiol, 32, 596, 10.1016/S0735-1097(98)00284-8 1999, FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study., Lancet, 354, 708, 10.1016/S0140-6736(99)07349-3 Fox, 2005, 5-year outcome of an interventional strategy in non–ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial, Lancet, 366, 914, 10.1016/S0140-6736(05)67222-4 Roe, 2000, Circulation, 102, 1101, 10.1161/01.CIR.102.10.1101 Gogo, 2007, Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE quality improvement initiative), Am J Cardiol, 99, 1222, 10.1016/j.amjcard.2006.12.037 Bhatt, 2004, Utilization of early invasive management strategies for high-risk patients with non–ST-segment elevation acute coronary syndromes: results from the CRUSADE quality improvement initiative, JAMA, 292, 2096, 10.1001/jama.292.17.2096 Erne, 2007, Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial, JAM, 297, 1985, 10.1001/jama.297.18.1985 Budaj, 2003, Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE), Am Heart J, 146, 999, 10.1016/S0002-8703(03)00509-X Steinberg, 2007, Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry), Am J Cardiol, 99, 1212, 10.1016/j.amjcard.2006.12.039 Roe MT, Chen AY, Mehta RH, et al. Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes. 2007;116:1153-1161. Miller, 2006, Moving from evidence to practice in the care of patients who have acute coronary syndrome, Cardiol Clin, 24, 87, 10.1016/j.ccl.2005.09.008 Mehta, 2005, Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials, JAMA, 293, 2908, 10.1001/jama.293.23.2908 Yusuf, 2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746 Cattaneo, 2006, P2Y12 receptor antagonists: a rapidly expanding group of antiplatelet agents, Eur Heart J, 27, 1010, 10.1093/eurheartj/ehi851 Hurlen, 2002, Warfarin, aspirin, or both after myocardial infarction, N Engl J Med, 347, 969, 10.1056/NEJMoa020496 van Es, 2002, Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial, Lancet, 360, 109, 10.1016/S0140-6736(02)09409-6 Andreotti, 2006, Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients, Eur Heart J, 27, 519, 10.1093/eurheartj/ehi485 Grudy, 2004, Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines, Circulation, 110, 227, 10.1161/01.CIR.0000133317.49796.0E Schwartz, 2001, Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial, JAMA, 285, 1711, 10.1001/jama.285.13.1711 Cannon, 2004, Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N Engl J Med, 350, 1495, 10.1056/NEJMoa040583 Pedersen, 2005, High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial, JAMA, 294, 2437, 10.1001/jama.294.19.2437 Freemantle, 1999, beta Blockade after myocardial infarction: systematic review and meta regression analysis, BMJ, 318, 1730, 10.1136/bmj.318.7200.1730 Chen, 2005, Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial, Lancet, 366, 1622, 10.1016/S0140-6736(05)67661-1 Dargie, 2001, Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial, Lancet, 357, 1385, 10.1016/S0140-6736(00)04560-8 1998, ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials., Circulation, 97, 2202, 10.1161/01.CIR.97.22.2202 Ferrari, 2006, Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study, Arch Intern Med, 166, 659, 10.1001/archinte.166.6.659 Pfeffer, 2003, Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both, N Engl J Med, 349, 1893, 10.1056/NEJMoa032292 Alexander, 2005, Excess dosing of antiplatelet and antithrombin agents in the treatment of non–ST-segment elevation acute coronary syndromes, JAMA, 294, 3108, 10.1001/jama.294.24.3108 Boden, 2007, Optimal medical therapy with or without PCI for stable coronary disease, N Engl J Med, 356, 1503, 10.1056/NEJMoa070829